• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NAD(P)H:醌氧化还原酶在正常及帕金森病黑质中的表达

Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra.

作者信息

van Muiswinkel F L, de Vos R A I, Bol J G J M, Andringa G, Jansen Steur E N H, Ross D, Siegel D, Drukarch B

机构信息

Department of Medical Pharmacology, Institute for Clinical and Experimental Neurosciences (ICEN), VU University Medical Center, Vrije Universiteit, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands.

出版信息

Neurobiol Aging. 2004 Oct;25(9):1253-62. doi: 10.1016/j.neurobiolaging.2003.12.010.

DOI:10.1016/j.neurobiolaging.2003.12.010
PMID:15312971
Abstract

Dopamine (DA) autooxidation, and consequent formation of neurotoxic DA-derived quinones and reactive oxygen species, has been implicated in dopaminergic cell death and, hence, in the pathogenesis of Parkinson's disease (PD). Stimulation of pathways involved in the detoxication of DA-quinones in the brain is hypothesized to be an effective means to limit oxidative stress and to confer neuroprotection in PD. In this respect, the inducible flavoprotein NAD(P)H:quinone oxidoreductase (NQO1) is of particular interest as it is directly implicated in the detoxication of DA-quinones and, in addition, has broad spectrum anti-oxidant properties. To study the potential pathophysiological role of NQO1 in PD, the cellular expression of NQO1 was examined in the mesencephalon of PD patients and age-matched controls. In the substantia nigra pars compacta (SNpc), NQO1 was found to be expressed in astroglial and endothelial cells and, albeit less frequently, also in dopaminergic neurons. Moreover, while overt NQO1 immunoreactivity was absent in the surrounding nervous tissue, in the Parkinsonian SNpc a marked increase in the astroglial and neuronal expression of NQO1 was consistently observed.

摘要

多巴胺(DA)的自动氧化以及由此产生的神经毒性DA衍生醌类和活性氧物质,被认为与多巴胺能细胞死亡有关,因此也与帕金森病(PD)的发病机制有关。据推测,刺激大脑中参与DA-醌解毒的途径是限制氧化应激并在PD中提供神经保护的有效手段。在这方面,可诱导的黄素蛋白NAD(P)H:醌氧化还原酶(NQO1)特别受关注,因为它直接参与DA-醌的解毒,此外还具有广谱抗氧化特性。为了研究NQO1在PD中的潜在病理生理作用,我们检测了PD患者和年龄匹配对照组中脑NQO1的细胞表达。在黑质致密部(SNpc)中,发现NQO1在星形胶质细胞和内皮细胞中表达,尽管频率较低,但在多巴胺能神经元中也有表达。此外,虽然周围神经组织中没有明显的NQO1免疫反应性,但在帕金森病的SNpc中,始终观察到星形胶质细胞和神经元中NQO1的表达显著增加。

相似文献

1
Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra.NAD(P)H:醌氧化还原酶在正常及帕金森病黑质中的表达
Neurobiol Aging. 2004 Oct;25(9):1253-62. doi: 10.1016/j.neurobiolaging.2003.12.010.
2
Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.帕金森病黑质中脑源性神经营养因子信使核糖核酸表达降低。
Exp Neurol. 2000 Nov;166(1):127-35. doi: 10.1006/exnr.2000.7483.
3
Drug treatment of Parkinson's disease. Time for phase II.帕金森病的药物治疗。进入二期阶段的时候了。
Biochem Pharmacol. 2000 May 1;59(9):1023-31. doi: 10.1016/s0006-2952(99)00340-8.
4
No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes.帕金森病与醌氧化还原酶(NQO1、NQO2)基因多态性之间无关联。
Neurosci Lett. 2005 Mar 3;375(3):178-80. doi: 10.1016/j.neulet.2004.11.009. Epub 2004 Dec 10.
5
Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra.6-羟基多巴胺处理对大鼠黑质中神经元和胶质细胞的犬尿氨酸转氨酶-I(KAT-I)免疫反应性的影响。
Acta Neuropathol. 2006 Aug;112(2):127-37. doi: 10.1007/s00401-006-0086-4. Epub 2006 Jun 21.
6
Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.帕金森病1-甲基-4-苯基-1,2,3,6-四氢吡啶/丙磺舒渐进性神经退行性小鼠模型黑质致密部神经元凋亡的早期迹象。
Neuroscience. 2006 Jun 19;140(1):67-76. doi: 10.1016/j.neuroscience.2006.02.007. Epub 2006 Mar 14.
7
Iron-dependent enzymes in Parkinson's disease.帕金森病中的铁依赖性酶。
J Neural Transm Suppl. 1995;46:157-64.
8
Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.帕金森病、帕金森叠加型阿尔茨海默病及阿尔茨海默病患者中脑多巴胺转运体和酪氨酸羟化酶mRNA的差异修饰
Mov Disord. 1997 Nov;12(6):885-97. doi: 10.1002/mds.870120609.
9
Effects of cysteamine on MPTP-induced dopaminergic neurodegeneration in mice.半胱胺对 MPTP 诱导的小鼠多巴胺能神经元变性的影响。
Brain Res. 2010 Jun 4;1335:74-82. doi: 10.1016/j.brainres.2010.03.079. Epub 2010 Apr 7.
10
Glial reactions in Parkinson's disease.帕金森病中的胶质反应。
Mov Disord. 2008 Mar 15;23(4):474-83. doi: 10.1002/mds.21751.

引用本文的文献

1
Oxidative Stress: Pathological Driver in Chronic Neurodegenerative Diseases.氧化应激:慢性神经退行性疾病的病理驱动因素
Antioxidants (Basel). 2025 Jun 9;14(6):696. doi: 10.3390/antiox14060696.
2
Impact of NQO1 dysregulation in CNS disorders.NQO1 失调对中枢神经系统疾病的影响。
J Transl Med. 2024 Jan 2;22(1):4. doi: 10.1186/s12967-023-04802-3.
3
Role of Astrogliosis in the Pathogenesis of Parkinson's Disease: Insights into Astrocytic Nrf2 Pathway as a Potential Therapeutic Target.星形胶质细胞增生在帕金森病发病机制中的作用:星形胶质细胞 Nrf2 通路作为潜在治疗靶点的见解。
CNS Neurol Disord Drug Targets. 2024;23(8):1015-1029. doi: 10.2174/0118715273270473231002104610.
4
Ferroptosis and Neurodegenerative Diseases: Insights into the Regulatory Roles of SLC7A11.铁死亡与神经退行性疾病:对溶质载体家族7成员11(SLC7A11)调控作用的见解
Cell Mol Neurobiol. 2023 Aug;43(6):2627-2642. doi: 10.1007/s10571-023-01343-7. Epub 2023 Mar 29.
5
C/EBPβ/AEP is age-dependently activated in Parkinson's disease and mediates α-synuclein in the gut and brain.C/EBPβ/AEP在帕金森病中随年龄增长而被激活,并在肠道和大脑中介导α-突触核蛋白。
NPJ Parkinsons Dis. 2023 Jan 6;9(1):1. doi: 10.1038/s41531-022-00430-8.
6
Nrf2 is predominantly expressed in hippocampal neurons in a rat model of temporal lobe epilepsy.在颞叶癫痫大鼠模型中,Nrf2主要在海马神经元中表达。
Cell Biosci. 2023 Jan 4;13(1):3. doi: 10.1186/s13578-022-00951-y.
7
PhenoExam: gene set analyses through integration of different phenotype databases.PhenoExam:通过整合不同表型数据库进行基因集分析。
BMC Bioinformatics. 2022 Dec 31;23(1):567. doi: 10.1186/s12859-022-05122-x.
8
Review on NAD(P)H dehydrogenase quinone 1 (NQO1) pathway.NAD(P)H 脱氢酶醌 1(NQO1)途径综述。
Mol Biol Rep. 2022 Sep;49(9):8907-8924. doi: 10.1007/s11033-022-07369-2. Epub 2022 Mar 28.
9
Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson's Disease.用于治疗帕金森病的新型双NRF2诱导剂和选择性单胺氧化酶B抑制剂系列
Antioxidants (Basel). 2022 Jan 27;11(2):247. doi: 10.3390/antiox11020247.
10
A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer's and Parkinson's Diseases.神经炎症的Nrf2信号通路视角:阿尔茨海默病和帕金森病的潜在治疗靶点
Front Cell Neurosci. 2022 Jan 21;15:787258. doi: 10.3389/fncel.2021.787258. eCollection 2021.